Skip to main content
Top
Published in: Annals of Hematology 7/2014

01-07-2014 | Letter to the Editor

A rare IgM multiple myeloma with aberrant PAX5 expression mimicking lymphoplasmacytic lymphoma

Authors: Z. Xu, R. Van Der Jagt, C. Faught, M. Beaulieu Bergeron

Published in: Annals of Hematology | Issue 7/2014

Login to get access

Excerpt

Dear Editor, …
Literature
1.
go back to reference Swerdlow SH, Campo E, Harris NL et al (2008) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. International Agency for Research on Cancer, Lyon Swerdlow SH, Campo E, Harris NL et al (2008) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. International Agency for Research on Cancer, Lyon
2.
go back to reference Bergsagel PL, Kuehl WM (2005) Molecular pathogenesis and a consequent classification of multiple myeloma. J Clin Oncol 23:6333–6338PubMedCrossRef Bergsagel PL, Kuehl WM (2005) Molecular pathogenesis and a consequent classification of multiple myeloma. J Clin Oncol 23:6333–6338PubMedCrossRef
3.
go back to reference Kyle RA, Gertz MA, Witzig TE, Lust JA, Lacy MQ, Dispenzieri A, Fonseca R, Rajkumar SV, Offord JR, Larson DR, Plevak ME, Therneau TM (2003) Greipp PR Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc 78:21–33PubMedCrossRef Kyle RA, Gertz MA, Witzig TE, Lust JA, Lacy MQ, Dispenzieri A, Fonseca R, Rajkumar SV, Offord JR, Larson DR, Plevak ME, Therneau TM (2003) Greipp PR Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc 78:21–33PubMedCrossRef
4.
go back to reference An G, Xu Y, Shi L, Zou D, Deng S, Sui W, Xie Z, Hao M, Chang H, Qiu L (2013) t(11;14) multiple myeloma: a subtype associated with distinct immunological features, immunophenotypic characteristics but divergent outcome. Leuk Res 37:1251–1257PubMedCrossRef An G, Xu Y, Shi L, Zou D, Deng S, Sui W, Xie Z, Hao M, Chang H, Qiu L (2013) t(11;14) multiple myeloma: a subtype associated with distinct immunological features, immunophenotypic characteristics but divergent outcome. Leuk Res 37:1251–1257PubMedCrossRef
5.
go back to reference Avet-Loiseau H, Garand R, Lodé L, Harousseau J, Bataille R (2003) Translocation t(11;14)(q13;q32) is the hallmark of IgM, IgE, and nonsecretory multiple myeloma variants. Blood 101:1570–1571PubMedCrossRef Avet-Loiseau H, Garand R, Lodé L, Harousseau J, Bataille R (2003) Translocation t(11;14)(q13;q32) is the hallmark of IgM, IgE, and nonsecretory multiple myeloma variants. Blood 101:1570–1571PubMedCrossRef
6.
go back to reference Lin P, Mahdavy M, Zhan F, Zhang HZ, Katz RL, Shaughnessy JD (2004) Expression of PAX5 in CD20-positive multiple myeloma assessed by immunohistochemistry and oligonucleotide microarray. Mod Pathol 17:1217–1222PubMedCrossRef Lin P, Mahdavy M, Zhan F, Zhang HZ, Katz RL, Shaughnessy JD (2004) Expression of PAX5 in CD20-positive multiple myeloma assessed by immunohistochemistry and oligonucleotide microarray. Mod Pathol 17:1217–1222PubMedCrossRef
Metadata
Title
A rare IgM multiple myeloma with aberrant PAX5 expression mimicking lymphoplasmacytic lymphoma
Authors
Z. Xu
R. Van Der Jagt
C. Faught
M. Beaulieu Bergeron
Publication date
01-07-2014
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 7/2014
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-013-1959-y

Other articles of this Issue 7/2014

Annals of Hematology 7/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.